title: Angiotensin-converting-enzyme inhibitors versus steroids as first-line drug treatment in Duchenne muscular dystrophy.
authors.forename: Stéphane
authors.initials: S
authors.lastname: Chabrier
authors.forename: Isabelle
authors.initials: I
authors.lastname: Desguerre
authors.forename: Mélanie
authors.initials: M
authors.lastname: Porte
authors.forename: Claude
authors.initials: C
authors.lastname: Payet
authors.forename: François
authors.initials: F
authors.lastname: Rivier
mesh_terms: D000293:Adolescent; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D009069:Movement Disorders / Q000209:etiology; D020388:Muscular Dystrophy, Duchenne / Q000150:complications / Q000188:drug therapy*; D013256:Steroids / Q000627:therapeutic use*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D013256:Steroids